Mesoblast Limited (MSB)

Index:

ASX 200

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $0.26
  • Currency: Australian Dollars
  • Shares Issued: 482.64m
Select chart: 1 week | 1 month | 3 month | 6 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 9.70 (63.43) (37.08)¢ n/a n/a n/a n/a 0.0%
30-Jun-26 43.49 (49.73) (31.29)¢ n/a n/a n/a n/a 0.0%
30-Jun-27 241.63 101.50 27.23¢ 4.8 n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Forecast Ratios

Year Ending Revenue/Share Price/Revenue per Share
30-Jun-25 $0.02 65.16
30-Jun-26 $0.09 14.54
30-Jun-27 $0.50 2.62

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue ($m)
30-Jun-2025 10 10 10 12 11 8
30-Jun-2026 44 44 44 120 118 170
30-Jun-2027 242 242 242 n/a n/a n/a
 
Earnings
30-Jun-2025 n/a n/a n/a n/a n/a n/a
30-Jun-2026 n/a n/a n/a 51.06¢ 51.96¢ 33.79¢
30-Jun-2027 27.23¢ 27.06¢ 26.34¢ n/a n/a n/a
 
Dividend
30-Jun-2025 n/a n/a n/a n/a n/a n/a
30-Jun-2026 n/a n/a n/a n/a n/a n/a
30-Jun-2027 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 1 1 1 1 1 1
Buy 2 2 2 2 2 2
Neutral 1 1 1 1 1 1
Sell 0 0 0 0 0 1
Strong Sell 0 0 0 0 0 0
No. of Brokers 4 4 4 4 4 5
 
Average Rec 7.50 7.50 7.50 7.50 7.50 6.50

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

MSB Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $0.26
Shares Issued 482.64m

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 1
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page